https://markets.businessinsider.com/news/stocks/replimune-group-trading-halted-volatility-trading-pause-1034924601
Replimune Group trading halted, volatility trading pause | Markets Insider
09:42 EDT Replimune (REPL) Group trading halted, volatility trading pauseElevate Your Investing Strategy: Take advantage of TipRanks Premium at...
replimunegrouptradingvolatilitypause
https://www.benzinga.com/quote/REPL
Replimune Group (REPL) Stock Price, Quote, News & History | Benzinga
Get real-time Replimune Group (REPL) stock price, charts, news, and analyst ratings on Benzinga. Access forecasts, historical data, and expert insights to...
stock pricenews historyreplimunegroupquote
https://www.biopharmadive.com/news/replimune-tudriqev-fda-approve-melanoma-rp1/827226/
Replimune rebounds to win FDA approval of melanoma drug | BioPharma Dive
The accelerated clearance follows two earlier rejections and the support of an advisory panel that disputed the arguments of FDA scientists.
to winfda approvalreplimunerebounds
https://www.replimune.com/
Oncolytic Immunotherapies | Replimune
Aug 6, 2026 - Replimune is a commercial-stage biotech company revolutionizing cancer treatment with a new class of oncolytic immunotherapies designed to activate a…
immunotherapiesreplimune
https://www.sofi.com/invest/stock/REPL/
Buy Replimune Group Stock - REPL Stock Price, Quote & News | SoFi
See real time price charts for REPL stock, historical data, and recent news. Buy REPL stock online with no commission fees.
group stockprice quotebuyreplimunenews
https://www.fiercebiotech.com/biotech/replimune-sheds-60-staff-after-fda-rejection-vows-continue-operations
Shedding 60% of staff, Replimune vows to continue operations
Apr 21, 2026 - Replimune is saying goodbye to a further 161 staffers across two Massachusetts sites.
sheddingstaffreplimunevowscontinue
https://www.prnewswire.com/news-releases/repl-lawsuit-alert-the-gross-law-firm-notifies-replimune-group-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-302520124.html
REPL LAWSUIT ALERT: The Gross Law Firm Notifies Replimune Group, Inc. Investors of a Class Action...
/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. (NASDAQ: REPL). Shareholders who purchased shares of...